Dana Y Fuhrman1,2,3, John A Kellum2, Emily L Joyce2,3, Yosuke Miyashita3, George V Mazariegos4, Armando Ganoza4, James E Squires5. 1. Department of Critical Care Medicine, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. 2. Department of Critical Care Medicine, The Center for Critical Care Nephrology, Pittsburgh, PA, USA. 3. Division of Pediatric Nephrology, Department of Pediatrics, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. 4. Hillman Center for Pediatric Liver Transplantation, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. 5. Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
Abstract
BACKGROUND: AKI after pediatric liver transplantation is associated with increased morbidity and mortality. The role of urinary biomarkers for the prediction of AKI in pediatric patients after liver transplantation has not been previously reported. The primary objective of this prospective pilot study was to determine the predictive capabilities of urinary KIM-1, NGAL, TIMP-2, and IGFBP7 for diagnosing AKI. METHODS: Sixteen children undergoing liver transplantation were enrolled in the study over a 19-month time period. The Kidney Disease Improving Outcomes criteria for urine output and serum creatinine were used to define AKI. Predictive ability was evaluated using the area under the curve obtained by ROC analysis. RESULTS: AKI occurred in 6 (37.5%) of the patients between 2 and 4 days after transplant. There were no differences in any of the biomarkers prior to transplant. When obtained within 6 hours after transplant, the area under the ROC curve for predicting AKI was 0.758 (95% CI: 0.458-1.00) for KIM-1, 0.900 (95% CI: 0.724-1.00) for NGAL, and 0.933 (95% CI: 0.812-1.00) for the product of TIMP-2 and IGFBP7 ([TIMP-2]·[IGFBP7]). CONCLUSIONS: Our results show that both NGAL and [TIMP-2]·[IGFBP7] provide significant discrimination for AKI risk following liver transplant in children. Larger studies are needed to determine the optimal time point for measuring these biomarkers and to validate our findings.
BACKGROUND: AKI after pediatric liver transplantation is associated with increased morbidity and mortality. The role of urinary biomarkers for the prediction of AKI in pediatric patients after liver transplantation has not been previously reported. The primary objective of this prospective pilot study was to determine the predictive capabilities of urinary KIM-1, NGAL, TIMP-2, and IGFBP7 for diagnosing AKI. METHODS: Sixteen children undergoing liver transplantation were enrolled in the study over a 19-month time period. The Kidney Disease Improving Outcomes criteria for urine output and serum creatinine were used to define AKI. Predictive ability was evaluated using the area under the curve obtained by ROC analysis. RESULTS: AKI occurred in 6 (37.5%) of the patients between 2 and 4 days after transplant. There were no differences in any of the biomarkers prior to transplant. When obtained within 6 hours after transplant, the area under the ROC curve for predicting AKI was 0.758 (95% CI: 0.458-1.00) for KIM-1, 0.900 (95% CI: 0.724-1.00) for NGAL, and 0.933 (95% CI: 0.812-1.00) for the product of TIMP-2 and IGFBP7 ([TIMP-2]·[IGFBP7]). CONCLUSIONS: Our results show that both NGAL and [TIMP-2]·[IGFBP7] provide significant discrimination for AKI risk following liver transplant in children. Larger studies are needed to determine the optimal time point for measuring these biomarkers and to validate our findings.
Authors: Luís Taddeo Filho; Antonio Jose Grande; Tamy Colonetti; Éverton Simon Possamai Della; Maria Inês da Rosa Journal: Pediatr Nephrol Date: 2017-06-14 Impact factor: 3.714
Authors: Rajit K Basu; Anne Andrews; Catherine Krawczeski; Peter Manning; Derek S Wheeler; Stuart L Goldstein Journal: Pediatr Crit Care Med Date: 2013-06 Impact factor: 3.624
Authors: Michael R Bennett; Edward Nehus; Christopher Haffner; Qing Ma; Prasad Devarajan Journal: Pediatr Nephrol Date: 2014-10-28 Impact factor: 3.714
Authors: Azra Bihorac; Lakhmir S Chawla; Andrew D Shaw; Ali Al-Khafaji; Danielle L Davison; George E Demuth; Robert Fitzgerald; Michelle Ng Gong; Derrel D Graham; Kyle Gunnerson; Michael Heung; Saeed Jortani; Eric Kleerup; Jay L Koyner; Kenneth Krell; Jennifer Letourneau; Matthew Lissauer; James Miner; H Bryant Nguyen; Luis M Ortega; Wesley H Self; Richard Sellman; Jing Shi; Joely Straseski; James E Szalados; Scott T Wilber; Michael G Walker; Jason Wilson; Richard Wunderink; Janice Zimmerman; John A Kellum Journal: Am J Respir Crit Care Med Date: 2014-04-15 Impact factor: 21.405